Anticoagulants Market Report by Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low Molecular Weight Heparin (LMWH), Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant, Injectable Anticoagulant), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, and Others), Application (Atrial Fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others), and Region 2026-2034

Anticoagulants Market Report by Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low Molecular Weight Heparin (LMWH), Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant, Injectable Anticoagulant), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, and Others), Application (Atrial Fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others), and Region 2026-2034

Report Format: PDF+Excel | Report ID: SR112026A4360

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Anticoagulants Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Novel Oral Anticoagulants (NOACs)
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Heparin and Low Molecular Weight Heparin (LMWH)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Vitamin K Antagonist
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Route of Administration
    7.1    Oral Anticoagulant
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Injectable Anticoagulant
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Stores
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Application
    9.1    Atrial Fibrillation and Heart Attack
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Stroke
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Deep Vein Thrombosis (DVT)
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Pulmonary Embolism (PE)
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10   Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Alexion Pharmaceuticals Inc
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Aspen Holdings
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Bayer AG
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Boehringer Ingelheim International GmbH
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    Bristol-Myers Squibb Company
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Daiichi Sankyo Company Limited
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Dr. Reddy’s Laboratories Ltd
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    GlaxoSmithKline plc
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Johnson & Johnson Private Limited
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Pfizer Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Sanofi
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
Figure 2: Global: Anticoagulants Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2025
Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2025
Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2025
Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2025
Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2025
Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 33: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 34: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 35: Global: Anticoagulants (Pulmonary Embolism-PE) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 36: Global: Anticoagulants (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 39: North America: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 41: United States: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 43: Canada: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 47: China: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 49: Japan: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 51: India: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 55: Australia: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 59: Others: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 61: Europe: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 63: Germany: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 65: France: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 69: Italy: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 71: Spain: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 73: Russia: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 75: Others: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 83: Others: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2025
Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 88: Global: Anticoagulants Industry: SWOT Analysis
Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Table 7: Global: Anticoagulants Market: Competitive Structure
Table 8: Global: Anticoagulants Market: Key Players

Anticoagulants Market Report by Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low Molecular Weight Heparin (LMWH), Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant, Injectable Anticoagulant), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, and Others), Application (Atrial Fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others), and Region 2026-2034
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: [email protected]

Client Testimonials